Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 21, 2012
Jubilant Biosys Limited, Bangalore announced today that they have entered into drug discovery collaboration with Mnemosyne Pharmaceutical Inc, Providence, Rhode Island that will seek to identify preclinical candidates in the area of neuropsychiatric ...
read more
Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, and Orion Corporation (Orion), the largest pharmaceutical company in Finland, today announced a path breaking drug discovery collaboration to discover small molecule inhibitors ...
read more
Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences, announced today that it has expanded its drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium. The alliance was forged initially in the year 2011 and aims ...
read more
The Investigational New Drug (IND) relates to a novel molecule targeting prostate cancer which will now progress towards the next stage of development, with clinical trials expected next year
read more
Monday, December 09, 2019
Jubilant Biosys announced commencement of two expansion projects in Greater Noida and Bengaluru.
read more
Tuesday, January 13, 2026
Jubilant Biosys Limited announced the opening of a new discovery and preclinical facility at Noida [Delhi NCR], doubling its overall chemistry capacity for discovery research and scale-up projects.
read more
Friday, February 15, 2019
Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area.
read more
Jubilant Biosys and Collaborative Drug Discovery (CDD) announced Jubilant has chosen CDD Vault as their discovery research informatics platform for the next 5 years.
read more
Monday, September 19, 2016
Jubilant Biosys Ltd has announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
Jubilant HollisterStier announced the appointment of Chris Preti as President. He brings more than 25 years of broad pharmaceutical industry experience to JHS.
read more
Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer ...
read more
Friday, September 15, 2023
Jubilant HollisterStier Contract Manufacturing announced the appointment of Ian Fuller as the new Vice President of Operations.
read more
Wednesday, March 17, 2021
Jubilant Life Sciences has signed new contract with Eli Lilly for contract manufacturing of a treatment for COVID-19.
read more
Thursday, August 15, 2013
Jubilant HollisterStier announced today that the Montreal-based manufacturing facility has completed the first phase of an expansion of their sterile manufacturing capacity, with the addition of a new ampoule filling line utilizing a rigid barrier ...
read more